
Clinical signs of acanthamoeba keratitis are, in the early stages, grey-dirty epithelium, pseudodendritiformic epitheliopathy, perineuritis, multifocal stromal infiltrates, ring infiltrates, and, in the later stages, scleritis, iris atrophy, anterior synechiae, secondary glaucoma, mature cataracts, and chorioretinitis. The finding emphasizes that pre-testing the in vitro susceptibility of the AK isolate with the non-nutrient E. coli agar plate assay against the anti‐amoebic drug intended for treatment will give valuable information on whether the drug is likely to be active on the Acanthamoeba isolate in vivo. Surgical treatment options such as corneal cryotherapy, amniotic membrane transplantation, riboflavin‐UVA cross‐linking, and penetrating keratoplasty are applied in therapy-resistant cases.
Like
Save
Share